Function and Emotion in Everyday Life with Type 1 Diabetes: FEEL-T1D

1 型糖尿病日常生活中的功能和情绪:FEEL-T1D

基本信息

  • 批准号:
    10374068
  • 负责人:
  • 金额:
    $ 74.08万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-04-01 至 2025-03-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT Emotional well-being and everyday life function are important outcomes for people with type 1 diabetes (T1D) and are robust contributors to overall quality of life. Various indicators of emotional distress (e.g., negative mood, depressive symptoms, diabetes distress) are elevated in people with T1D. Likewise, function, or the ability to perform necessary or desired daily life activities, is also adversely impacted: symptoms of hypo- and hyperglycemia and T1D self-management tasks can disrupt participation in everyday work, leisure, and social activities among people with T1D. While acute blood glucose levels and variability are thought to contribute to diminished function and well-being in people with T1D, these relationships are poorly understood. Diabetes research to date has primarily relied on global, retrospective measures of blood glucose, function and emotional well-being that cannot capture their complex dynamic relationships as they unfold in everyday life contexts. To overcome this limitation, the Function and Emotion in Everyday Life with Type 1 Diabetes (FEEL- T1D) study is the first large-scale study to integrate continuous glucose monitoring (CGM), accelerometry, and ecological momentary assessment (EMA) to disentangle the short-term dynamic relationships between blood glucose, function, and emotional well-being in adults with type 1 diabetes. In the FEEL-T1D study, 200 adults with T1D will complete a baseline survey battery followed by 14 days of intensive longitudinal data collection using blinded CGM coupled with EMA surveys, ambulatory cognitive tasks, and accelerometer wear. These tools will be used to assess blood glucose, emotional well-being (stress, positive and negative affect, diabetes distress), function (self-reported activity performance, objective cognitive function, physical activity), and covariates that may moderate or confound the relationships of interest. Multiple metrics characterizing blood glucose (acute glucose level, glycemic excursions, glycemic variability, and % time in glycemic ranges) will be derived from CGM data to determine which have the most pronounced relationships with well-being and function on both a short-term and day-to-day basis. By clarifying which metrics of blood glucose are most closely related to clinical and patient-reported outcomes, these analyses will be foundational to the individualization of treatment recommendations and lead to the development of innovative just-in-time adaptive interventions to address the most potent predictors of health and well-being. The study's specific aims are as follows: Aim 1: Understand within-person dynamic relationships between blood glucose metrics, function, and emotional well-being through multi-level time-series analyses using CGM, EMA, and accelerometer data. Aim 2: Examine moderators of short-term and daily relationships, such as demographics, clinical characteristics, and HbA1c, between blood glucose metrics, function, and emotional well-being. Aim 3: Understand how short-term dynamics between blood glucose metrics, function, and emotional well-being are predictive of global function, well-being, and quality of life.
项目总结/文摘

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JEFFREY S GONZALEZ其他文献

JEFFREY S GONZALEZ的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JEFFREY S GONZALEZ', 18)}}的其他基金

Function and Emotion in Everyday Life with Type 1 Diabetes: FEEL-T1D
1 型糖尿病日常生活中的功能和情绪:FEEL-T1D
  • 批准号:
    9904611
  • 财政年份:
    2019
  • 资助金额:
    $ 74.08万
  • 项目类别:
New York Regional Center for Diabetes Translation Research
纽约糖尿病翻译研究区域中心
  • 批准号:
    10480940
  • 财政年份:
    2016
  • 资助金额:
    $ 74.08万
  • 项目类别:
New York Regional Center for Diabetes Translation Research
纽约糖尿病翻译研究区域中心
  • 批准号:
    10704634
  • 财政年份:
    2016
  • 资助金额:
    $ 74.08万
  • 项目类别:
New York Regional Center for Diabetes Translation Research
纽约糖尿病翻译研究区域中心
  • 批准号:
    10704640
  • 财政年份:
    2016
  • 资助金额:
    $ 74.08万
  • 项目类别:
New York Regional Center for Diabetes Translation Research
纽约糖尿病翻译研究区域中心
  • 批准号:
    10290453
  • 财政年份:
    2016
  • 资助金额:
    $ 74.08万
  • 项目类别:
New York Regional Center for Diabetes Translation Research
纽约糖尿病翻译研究区域中心
  • 批准号:
    10480933
  • 财政年份:
    2016
  • 资助金额:
    $ 74.08万
  • 项目类别:
New York Regional Center for Diabetes Translation Research
纽约糖尿病翻译研究区域中心
  • 批准号:
    9354474
  • 财政年份:
    2016
  • 资助金额:
    $ 74.08万
  • 项目类别:
New York Regional Center for Diabetes Translation Research
纽约糖尿病翻译研究区域中心
  • 批准号:
    10704638
  • 财政年份:
    2016
  • 资助金额:
    $ 74.08万
  • 项目类别:
New York Regional Center for Diabetes Translation Research
纽约糖尿病翻译研究区域中心
  • 批准号:
    10016091
  • 财政年份:
    2016
  • 资助金额:
    $ 74.08万
  • 项目类别:
New York Regional Center for Diabetes Translation Research
纽约糖尿病翻译研究区域中心
  • 批准号:
    10290452
  • 财政年份:
    2016
  • 资助金额:
    $ 74.08万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 74.08万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 74.08万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 74.08万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 74.08万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 74.08万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 74.08万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 74.08万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 74.08万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 74.08万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 74.08万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了